{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:37:46Z","timestamp":1740141466164,"version":"3.37.3"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K07217","JP20K07195","JP23590173","JP23K06253","JP23K06209","JP15K08092"],"award-info":[{"award-number":["JP19K07217","JP20K07195","JP23590173","JP23K06253","JP23K06209","JP15K08092"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2135"],"award-info":[{"award-number":["JPMJSP2135"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.dmpk.2024.101035","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T18:43:13Z","timestamp":1730832193000},"page":"101035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of obesity on pharmacokinetics of transdermal fentanyl: Single-center retrospective study and animal study"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1817-5765","authenticated-orcid":false,"given":"Satoshi","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Gake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Takabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akari","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Tamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Sawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Ohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Shiomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-8514","authenticated-orcid":false,"given":"Arimi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7777-7879","authenticated-orcid":false,"given":"Tsutomu","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2954-1532","authenticated-orcid":false,"given":"Yoshimichi","family":"Sai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2024.101035_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ctrv.2006.03.001","article-title":"Opioid switching: a systematic and critical review","volume":"32","author":"Mercadante","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.dmpk.2024.101035_bib2","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dmpk.2024.101035_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15360288.2011.620689","article-title":"Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine, and fentanyl","volume":"25","author":"Nakamura","year":"2011","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.dmpk.2024.101035_bib4","first-page":"633","article-title":"Transdermal therapeutic fentanyl-system (TTS-F)","volume":"18","author":"Mystakidou","year":"2004","journal-title":"In Vivo"},{"key":"10.1016\/j.dmpk.2024.101035_bib5","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpain.2014.08.010","article-title":"The fentanyl story","volume":"15","author":"Stanley","year":"2014","journal-title":"J Pain"},{"key":"10.1016\/j.dmpk.2024.101035_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00000542-199509000-00004","article-title":"Biopharmaceutics of a new transdermal fentanyl device","volume":"83","author":"Fiset","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.dmpk.2024.101035_bib7","first-page":"1029","article-title":"Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients","volume":"14","author":"Solassol","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.dmpk.2024.101035_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0304-3959(95)00180-8","article-title":"Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain","volume":"64","author":"Donner","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.dmpk.2024.101035_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpainsymman.2004.12.010","article-title":"Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial","volume":"30","author":"Morita","year":"2005","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.dmpk.2024.101035_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ijc.11416","article-title":"Long-term cancer pain management in morphine pre-treated and opioid naive patients with transdermal fentanyl","volume":"107","author":"Mystakidou","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dmpk.2024.101035_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0885-3924(95)00162-X","article-title":"Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients","volume":"11","author":"Korte","year":"1996","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.dmpk.2024.101035_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/bja\/aei195","article-title":"Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients \u2020 \u2020Presented in abstract form at the Annual Meeting of the American Society of Anesthesiologists, Las Vegas, October 26, 2004","volume":"95","author":"Shibutani","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.dmpk.2024.101035_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1526-4637.2000.00030.x","article-title":"Assessing the impact of heat on the systemic delivery of fentanyl through the transdermal fentanyl delivery system","volume":"1","author":"Shomaker","year":"2000","journal-title":"Pain Med"},{"key":"10.1016\/j.dmpk.2024.101035_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1526-5900(03)00618-7","article-title":"The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat","volume":"4","author":"Ashburn","year":"2003","journal-title":"J Pain"},{"key":"10.1016\/j.dmpk.2024.101035_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/FPC.0000000000000032","article-title":"Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study","volume":"24","author":"Barratt","year":"2014","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.dmpk.2024.101035_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000213572","article-title":"Transdermal fentanyl disposition in elderly subjects","volume":"40","author":"Holdsworth","year":"1994","journal-title":"Gerontology"},{"key":"10.1016\/j.dmpk.2024.101035_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pain.2009.04.012","article-title":"Transdermal fentanyl in cachectic cancer patients","volume":"144","author":"Heiskanen","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.dmpk.2024.101035_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/AJP.0b013e318266f6a5","article-title":"Serum concentration of fentanyl during conversion from intravenous to transdermal administration to patients with chronic cancer pain","volume":"29","author":"Nomura","year":"2013","journal-title":"Clin J Pain"},{"key":"10.1016\/j.dmpk.2024.101035_bib19","first-page":"148","article-title":"The Zucker-fatty rat: a review","volume":"36","author":"Bray","year":"1977","journal-title":"Fed Proc"},{"key":"10.1016\/j.dmpk.2024.101035_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ilar.32.3.4","article-title":"Zucker (fa\/fa) Rat","volume":"32","author":"Kava","year":"1990","journal-title":"ILAR J"},{"year":"2018","series-title":"WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","key":"10.1016\/j.dmpk.2024.101035_bib21"},{"key":"10.1016\/j.dmpk.2024.101035_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000542-199301000-00007","article-title":"Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics","volume":"78","author":"Portenoy","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1016\/j.dmpk.2024.101035_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1023\/A:1023294632129","article-title":"Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference method","volume":"26","author":"Hisaka","year":"1998","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.dmpk.2024.101035_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.dmpk.2024.101035_bib25","first-page":"987","article-title":"Examination committee of criteria for \u201cobesity disease\u201d in Japan; Japan society for the study of obesity. New criteria for \u201cobesity disease\u201d in Japan","volume":"66","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.dmpk.2024.101035_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bja\/aen103","article-title":"Assessment of pain","volume":"101","author":"Breivik","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.dmpk.2024.101035_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/bcp.13129","article-title":"A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients","volume":"83","author":"Kuip","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2024.101035_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198289","article-title":"Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer","volume":"13","author":"Kuip","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.dmpk.2024.101035_bib29","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1002\/cam4.2479","article-title":"Does transdermal fentanyl work in patients with low BMI? Patient-reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl","volume":"8","author":"Moryl","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.dmpk.2024.101035_bib30","first-page":"936","article-title":"Identification of cytochrome P450 3A1\/2 as the major P450 isoform responsible for the metabolism of fentanyl by rat liver microsomes","volume":"82","author":"Feierman","year":"1996","journal-title":"Anesth Analg"},{"key":"10.1016\/j.dmpk.2024.101035_bib31","first-page":"1072","article-title":"Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions","volume":"25","author":"Labroo","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2024.101035_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2133\/dmpk.DMPK-13-RG-110","article-title":"Mechanisms of lower maintenance dose of tacrolimus in obese patients","volume":"29","author":"Sawamoto","year":"2014","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2024.101035_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00000542-200304000-00011","article-title":"Simultaneous assessment of drug interactions with low- and high-extraction opioids: application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil","volume":"98","author":"Ibrahim","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.dmpk.2024.101035_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jclinane.2004.01.009","article-title":"Anesthesia in the obese patient: pharmacokinetic considerations","volume":"17","author":"Casati","year":"2005","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.dmpk.2024.101035_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jcph.641","article-title":"Exposure to fentanyl after transdermal patch administration for cancer pain management","volume":"56","author":"Bista","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2024.101035_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/aivt.2015.0003","article-title":"Review of the availability of in vitro and in silico methods for assessing dermal bioavailability","volume":"1","author":"Dumont","year":"2015","journal-title":"Appl In Vitro Toxicol"},{"key":"10.1016\/j.dmpk.2024.101035_bib37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.2042-7158.1988.tb06996.x","article-title":"Binding of drugs to human skin: influencing factors and the role of tissue lipids","volume":"40","author":"Walter","year":"1988","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.dmpk.2024.101035_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.taap.2003.07.015","article-title":"Fate of chemicals in skin after dermal application: does the in vitro skin reservoir affect the estimate of systemic absorption?","volume":"195","author":"Yourick","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dmpk.2024.101035_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041721","article-title":"Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling","volume":"7","author":"van Eijl","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.dmpk.2024.101035_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.0909-752x","article-title":"The influence of body mass index on skin susceptibility to sodium lauryl sulphate","volume":"8","author":"L\u00f6ffler","year":"2002","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.dmpk.2024.101035_bib41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2006.12.004","article-title":"Obesity and the skin: skin physiology and skin manifestations of obesity","volume":"56","author":"Yosipovitch","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.dmpk.2024.101035_bib42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12944-017-0608-1","article-title":"Characterization of skin function associated with obesity and specific correlation to local\/systemic parameters in American women","volume":"16","author":"Mori","year":"2017","journal-title":"Lipids Health Dis"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436724000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436724000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T03:50:38Z","timestamp":1739418638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436724000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":42,"alternative-id":["S1347436724000417"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2024.101035","relation":{},"ISSN":["1347-4367"],"issn-type":[{"type":"print","value":"1347-4367"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of obesity on pharmacokinetics of transdermal fentanyl: Single-center retrospective study and animal study","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2024.101035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101035"}}